Structure |
Chemical Name |
CAS |
MF |
 |
Parecoxib Impurity T |
198471-83-9 |
C19H18N2O5S |
 |
Ropivacaine Impurity 31 |
|
|
 |
Ropivacaine Impurity 40 |
|
|
 |
Sugammadex sodium Decomposition process Impurity 3 |
|
|
 |
Sugammadex sodium Org48301 Impurity |
|
|
 |
Topiroxostat Impurity Ⅱ-3 |
|
|
 |
Ivabradine related compound 9 |
85175-49-1 |
C12H13NO4 |
 |
Afatinib impurity 28 |
|
|
 |
blonanserin impurity O |
|
|
 |
Butyphthalide impurity 42 |
952412-79-2 |
C10H12O3 |
 |
Butyphthalide impurity 48 |
|
|
 |
Dapoxetine impurity 20 |
|
|
 |
Empagliflozin Impurity POE |
|
|
 |
Febuxostat Impurity 73 |
|
|
 |
Febuxostat Impurity 78 |
|
|
 |
Ibrutinib Impurity 21 |
1642571-08-1 |
C27H30N6O3 |
 |
Lenvatinib Impurity 22 |
|
|
 |
Moxifloxacin Impurity 47 |
|
|
 |
Parecoxib sodium Impurity 35 |
|
|
 |
Tofacitinib Impurity 20 |
1092578-44-3 |
C27H31N5O2S |
 |
Tofacitinib Impurity 88 |
|
|
 |
Vildagliptin Impurity ZA9 |
|
|
 |
Nintedanib Impurity K |
|
|
 |
13-Cis Vitamin A Palmitate |
26771-20-0 |
C36H60O2 |
 |
Apixaban Amino Acid Impurity |
2206825-87-6 |
C25H27N5O5 |
 |
Bortezomib Impurity 52 |
87304-47-0 |
C15H26BClO2 |
 |
Moxifloxacin Impurity 20 HCl |
959347-97-8 |
C21H25N3O4 |
 |
2-amino-3,5-dibromo-N-((1r,4r)-4-hydroxycyclohexyl)benzamide |
105735-86-2 |
C13H16Br2N2O2 |
 |
Palonosetron Impurity TM1-RR |
1022895-91-5 |
C15H23ClN2 |
 |
Eltrombopag Impurity 6 |
|
|
 |
(1r,4r)-4-((2-amino-3-bromobenzyl)amino)cyclohexanol hydrochloride |
|
C13H20BrClN2O |
 |
(1s,4s)-4-((2-amino-5-bromobenzyl)amino)cyclohexanol hydrochloride |
5579-35-1 |
C13H20BrClN2O |
 |
Moxifloxacin oxide Impurity |
|
|
 |
Edaravone Impurity 18 |
|
|
 |
Linagliptin Impurity 47 |
|
|
 |
(3R,5S,E)-7-(4-(4-fluorophenyl)-2-((2-hydroxy-N,2-dimethylpropyl)sulfonamido)-6-isopropylpyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid |
1715120-13-0 |
C25H34FN3O7S |
 |
Cabozantinib impurity 28 |
|
|
 |
Cabozantinib impurity 33 |
|
|
 |
Ondansetron Impurity 2 |
|
|
 |
Rivaroxaban Degradation Impurity C |
|
|
 |
Irsogladine Impurity DQJ |
61382-84-1 |
C9H6Cl2N4O |
 |
Pregabalin Impurity 7 |
70767-77-0 |
C8H13NO3 |
 |
Pregabalin Impurity 13 |
1089315-68-3 |
C7H11NO3 |
 |
Pralatrexate Impurity 7 |
|
|
 |
Pitavastatin Impurity 39 |
|
|
 |
Dapoxetine impurity 31 |
|
|
 |
Lenvatinib Impurity 36 |
|
|
 |
Sitafloxacin Impurity 19 |
|
|
 |
Febuxostat Impurity 97 |
|
|
 |
Dapoxetine impurity 32 |
|
|
 |
Olprinone Impurity D |
|
|
 |
Atracurium Impurity 30 |
|
|
 |
Canagliflozin Impurity 48 |
|
|
 |
Canagliflozin Impurity 54 |
|
|
 |
ICOFQCJKJOISKD-HSZRJFAPSA-N |
1435768-96-9 |
C26H35NO3 |
![4-[1-methoxy-2-(methylamino)ethyl]benzene-1,2-diol:hydrochloride](../cas/20180601/gif/74571-90-7.gif) |
4-[1-methoxy-2-(methylamino)ethyl]benzene-1,2-diol:hydrochloride |
74571-90-7 |
C10H16ClNO3 |
 |
(1-methylpiperidin-4-yl)(pyridin-2-yl)methanone |
517875-04-6 |
C12H16N2O |
 |
2-cyano-1,3-bis(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine |
55272-86-1 |
C16H24N8S2 |
 |
3-(4-(4-amino-5-chloro-2,3-dihydrobenzofuran-7-carboxamido)piperidin-1-yl)propyl 4-amino-5-chloro-2,3-dihydrobenzofuran-7-carboxylate |
|
|
![(1R,3R)-1-(benzo[d][1,3]dioxol-5-yl)-2-(dimethylglycyl)-2,3,4,9-tetrahydro-1H-pyrido [3,4-b]indole-3-carboxylate methyl](../cas/20200611/gif/2169996-11-4.gif) |
(1R,3R)-1-(benzo[d][1,3]dioxol-5-yl)-2-(dimethylglycyl)-2,3,4,9-tetrahydro-1H-pyrido [3,4-b]indole-3-carboxylate methyl |
2169996-11-4 |
C24H25N3O5 |
 |
Fulvestrant impurity G |
|
|
 |
4-tert-Butyl-N-(6-chloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl)benzenesulfonamide |
150727-06-3 |
C25H24ClN5O4S |
 |
GLICLAZIDE IMPURITY B |
|
|
 |
ISOPROMETHAZINE HYDROCHLORIDE |
5568-90-1 |
C17H21ClN2S |
 |
monocalcium mono((3R,5S,E)-7-(4-(2-fluorophenyl)-6-isopropyl-2- (N-methylmethylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6- enoate) |
|
|
 |
Benzenepropanoic acid, 4-(2-oxiranylmethoxy)- |
2167848-51-1 |
C12H14O4 |
 |
(S)-(+)-N,N-Dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine |
132335-46-7 |
C19H21NOS |
 |
D-Tryptophan, N-(trifluoroacetyl)- (9CI) |
22220-03-7 |
C13H11F3N2O3 |
 |
2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-N-(5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-1H-indazol-3-yl)benzamide |
|
|
![1H-benzo[d][1,2,3]triazol-1-yl 2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoate](../) |
1H-benzo[d][1,2,3]triazol-1-yl 2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoate |
|
|
 |
1-Ethyl-3(3-dimethylamino)urea |
32897-26-0 |
C8H19N3O |
 |
Brivaracetam Impurity 29 |
|
|
 |
L-erythro-Hexuronic acid, 3,5-dideoxy-, 1,1-dimethylethyl ester |
1501982-84-8 |
C10H18O5 |
 |
(Gly8-OH)-Carbetocin (Impurity B) |
|
|
 |
D-Asn4-Carbetocin (Impurity F) |
|
|
![Benzoic acid, 2-(1',6'-dihydro-6'-oxo-1'-phenyl[2,3'-bipyridin]-5'-yl)-, methyl ester](../cas/20210305/gif/543699-60-1.gif) |
Benzoic acid, 2-(1',6'-dihydro-6'-oxo-1'-phenyl[2,3'-bipyridin]-5'-yl)-, methyl ester |
543699-60-1 |
C24H18N2O3 |
 |
1,2-bis(2-methoxyphenoxy)ethane |
553-45-7 |
C16H18O4 |
![Dispiro[11H-benzo[5,6]cyclohepta[1,2-b]pyridine-11,2'-oxirane-3',4''-piperidine]-1''-carboxylic acid, 8-chloro-5,6-dihydro-, ethyl ester, 1-oxide](../cas/20210305/gif/1432057-93-6.gif) |
Dispiro[11H-benzo[5,6]cyclohepta[1,2-b]pyridine-11,2'-oxirane-3',4''-piperidine]-1''-carboxylic acid, 8-chloro-5,6-dihydro-, ethyl ester, 1-oxide |
1432057-93-6 |
C22H23ClN2O4 |
 |
Oseltamivir Impurity 109 |
|
|
 |
Oseltamivir Impurity 81 |
|
|
 |
Oseltamivir Impurity 71 |
|
|
 |
1-hydrazino-3-(methylthio)propan-2-ol |
14359-97-8 |
C4H12N2OS |
 |
Benzenemethanol, 4-(3-chloro-2-hydroxypropoxy)- |
293302-44-0 |
C10H13ClO3 |
 |
trans N-Benzyl Paroxetine |
105813-14-7 |
C26H26FNO3 |
 |
Lasmiditan Impurity 10 |
|
|
 |
Nilotinib N-Oxide Impurity 3 |
|
|
 |
Pemetrexed Impurity 51 |
|
|
![6-((S)-7-amino-5-azaspiro[2.4]heptan-5-yl)-8-chloro-7-fluoro-1-((1R,2S)-2-fluorocyclopropyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid](../) |
6-((S)-7-amino-5-azaspiro[2.4]heptan-5-yl)-8-chloro-7-fluoro-1-((1R,2S)-2-fluorocyclopropyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
|
|
 |
(S)-Tamsulosin Hydrochloride |
106463-19-8 |
C20H29ClN2O5S |
 |
2,2'-Bisnalmefene |
176220-84-1 |
C42H48N2O6 |
 |
4-Desmethoxypropoxyl-4-chloro Rabeprazole |
168167-42-8 |
C14H12ClN3OS |
 |
N-Desmethyl-4-hydroxy Tamoxifen (approx. 1:1 E/Z Mixture) |
110025-28-0 |
C25H27NO2 |
 |
Atracurium Impurity 33 |
|
|
 |
Tofacitinib Impurity 105 |
|
|
 |
Cabozantinib impurity Q |
|
|
 |
Gadobutrol Impurity 1 |
216670-14-3 |
C22H42ClLiN4O6 |
 |
Pemetrexed disodium EP Impurity B |
|
|
 |
Crisaborole Impurity 7 |
|
|
 |
Valnemulin EP Impurity A |
1624614-06-7 |
C31H52N2O6S |
 |
Olprinone Impurity F |
|
|